Graft-versus-host disease in the lungs: novel insights and treatments

A. Bergeron Lafaurie (Paris, France)

Source: International Congress 2018 – Respiratory medicine meets hematology
Session: Respiratory medicine meets hematology
Session type: Symposium
Number: 2116

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bergeron Lafaurie (Paris, France). Graft-versus-host disease in the lungs: novel insights and treatments. International Congress 2018 – Respiratory medicine meets hematology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives
Source: Eur Respir J 2005; 26: 984-985
Year: 2005


Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations
Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans
Year: 2013


Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010


Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020



Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities
Source: Eur Respir J 2014; 44: 513-522
Year: 2014



Defining severe obstructive lung disease in the biologic era: an endotype-based approach
Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019
Year: 2019



The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease
Source: International Congress 2018 – Scientific Year in Review
Year: 2018


Pulmonary Lymphangiomatosis – insights into an ultra-rare disease
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018



Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009


Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009


Cleaning agents and chronic lung disease: does the evidence support a link with COPD?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018


Introduction: systemic effects in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 1S
Year: 2003


Erdheim-Chester disease: Patterns and pulmonary involvement
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Lymphangiogenesis in chronic obstructive pulmonary disease (COPD): New insights in airways remodeling
Source: Annual Congress 2010 - Airways and lung mechanics in subjects of all ages
Year: 2010

Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015